gabexate has been researched along with Mitral Stenosis in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nonami, Y | 1 |
| Sasahashi, N | 1 |
| Satoh, K | 1 |
| Ogoshi, S | 1 |
| Tamiya, T | 1 |
1 other study available for gabexate and Mitral Stenosis
| Article | Year |
|---|---|
[A case report: mitral valve replacement for the patient with essential thrombocythemia].
Topics: Gabexate; Heart Valve Prosthesis; Humans; Male; Middle Aged; Mitral Valve; Mitral Valve Stenosis; Pe | 1993 |